Ownership history in CITIGROUP INC · 33 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 102,986 | -417,473 | -80.2% | 0.00% | $1.9M | $18.24 |
| 2025 Q3 | ADDED | 520,459 | +469,859 | +928.6% | 0.00% | $7.6M | $14.66 |
| 2025 Q3 | REDUCED | 50,600 | -683,186 | -93.1% | 0.00% | $742K | $14.66 |
| 2025 Q2 | ADDED | 733,786 | +683,186 | +1350.2% | 0.01% | $13.4M | $18.21 |
As of 2025 Q4 — sorted by position size